RecruitingPhase 2NCT03329313

Effects of Variation of Sodium Dialysate in ICU

Effects of Variation of Sodium Dialysate in ICU Acute Kiney Injury


Sponsor

University Hospital, Montpellier

Enrollment

158 participants

Start Date

Apr 19, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Intermittent hemodialysis/diafiltration is a current renal replacement therapy (RRT) institued for ICU patients with AKI. For a better clinical tolerance, iinternational guidelines advise to use cold dialysate, increase duration session, decrease blood and dialysate flows, and increase level of sodium dialysate concentration (≥ 145mmol/l). Indeed, the use of a Na concentration dialysate \> 145 mmol/l improves intradialytic hemodynamic tolerance but it may also induce fluid overload by the transfert of sodium from the dialysate compartment to the blood. Yet, fluid overload has been strongly associated with mortality in critically ills. The investigators hypothesized that the use of a level in sodium dialysate at 140 mmol/l with slow low efficiency daily dialysis-filtration (SLEDD-f) will permit a fair intradialytic hemodynamic tolerance without the adverse effect of intradiaclytic Na loading from the dialysate. Two randomized groups of ICU AKI patients treated by SLEDD-f will be compared in terms of intradialytic hemodynamic tolerance and overload accordong to 140 or 145 mmol/l of Na in the dialysate


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Highing sodium concentration dialysate and a drug called Lowering sodium concentration dialysate for people with acute kidney injury and renal replacement therapy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLowering sodium concentration dialysate

Concentration of sodium in dialysate at 140 mmol/l

DRUGHighing sodium concentration dialysate

Concentration of sodium in dialysate at 145 mmol/l


Locations(1)

Uhmontpellier

Montpellier, Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03329313


Related Trials